The Limited Times

Now you can see non-English news...

The bivalent vaccine will be opened early next month: it can strengthen immunity against mutant viruses

2022-11-25T02:44:05.353Z


The Fubitai bivalent vaccine is expected to be administered early next month, and citizens can take the "fourth dose" of vaccination. Guan Rihua, an honorary clinical associate professor of children and adolescents at the University of Hong Kong, said on a radio program today (25th) that at this stage it is recommended that people under the age of 50


The Fubitai bivalent vaccine is expected to be administered early next month, and citizens can take the "fourth dose" of vaccination.

Kwan Ri-wah, an honorary clinical associate professor of the Department of Pediatrics and Adolescents of the University of Hong Kong, said on a radio program today (25th) that at this stage it is recommended that people over the age of 50 be vaccinated with the "fourth shot", but whether people between the ages of 18 and 49 need to be vaccinated depends on manpower and resources .

He pointed out that the bivalent vaccine can strengthen the immunity against the mutant virus and provide a wider range of protection than the previous generation vaccine.


Recently, the epidemic has rebounded. He said that this week, there were more cases of "multi-system inflammatory syndrome" in children who recovered from the new crown virus infection. It shows that there are also small outbreaks of new crown virus infection in the group of children.


Guan Rihua pointed out that the bivalent vaccine can strengthen immunity against mutant viruses and provide a wider range of protection; people over the age of 50, or adults who need to go to high-risk places, people under the age of 18, or people with chronic diseases and weak resistance The weak can be vaccinated.

When asked whether people between the ages of 18 and 49 will be vaccinated, it depends on manpower and resources, but he said that "all three are enough for adults to prevent severe illness and even death."

When asked about the difference between the Fubita vaccine that has been used and the Fubita bivalent vaccine, he pointed out that both can provide good resistance, and the side effects after vaccination are similar, and the public can choose by themselves.

However, the bivalent vaccine cannot be vaccinated from the first to the third dose. "It is done in foreign countries."

▼November 9th, BB version of Fubitai started today Parents take their children to Children's Hospital for injection▼


In terms of infection among children, Guan Rihua mentioned that when Omircon was raging in April this year, some children developed "multi-system inflammatory syndrome" after recovering from the infection. The symptoms were persistent fever, skin rash, eye inflammation, tongue swelling, and various Internal organs are inflamed, and most people have to stay in the intensive care unit. 70 related cases have been reported.

He said that the number of confirmed cases had already dropped, but this week there were another 5 to 6 serious cases reported in children, and he was worried that the epidemic would resurface.

The current vaccination rate of the new crown vaccine from 6 months to 3 years old is still very unsatisfactory, only 20.3%. Parents are urged to take their children for injections.

New Crown Vaccine|The bivalent vaccine is expected to arrive in Hong Kong in a few days and will be vaccinated in early December as the fourth dose of the epidemic|It is recommended that students who have completed the vaccination do not need to take a daily quick test He Boliang: More accurate epidemic prevention.

11.24|Increase in confirmed cases The government will not relax the epidemic prevention measures for the time being The bivalent vaccine will be launched next month

Source: hk1

All news articles on 2022-11-25

You may like

Life/Entertain 2024-02-26T11:52:45.057Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.